Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Jaguar Health (JAGX) Shares Outstanding (2016 - 2025)

Jaguar Health (JAGX) has disclosed Shares Outstanding for 11 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1220.21% to $7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Dec 2025, up 1220.21% year-over-year, with the annual reading at $7.0 million for FY2025, 1220.21% up from the prior year.
  • Shares Outstanding for Q4 2025 was $9.0 at Jaguar Health, down from $3.7 million in the prior quarter.
  • The five-year high for Shares Outstanding was $46.1 million in Q3 2021, with the low at $9.0 in Q4 2021.
  • Average Shares Outstanding over 5 years is $5.2 million, with a median of $274682.5 recorded in 2023.
  • The sharpest move saw Shares Outstanding crashed 100.0% in 2022, then soared 40958422.22% in 2025.
  • Over 5 years, Shares Outstanding stood at $9.0 in 2021, then changed by 0.0% to $9.0 in 2022, then changed by 0.0% to $9.0 in 2023, then soared by 5871455.56% to $528440.0 in 2024, then skyrocketed by 1220.21% to $7.0 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $7.0 million, $3.7 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.